Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure. [electronic resource]
Producer: 20051031Description: 541-7 p. digitalISSN:- 1097-6744
- Adrenergic alpha-Antagonists -- pharmacology
- Angiotensin II -- metabolism
- Atrial Natriuretic Factor -- metabolism
- Biomarkers -- metabolism
- Carbazoles -- pharmacology
- Carvedilol
- Endothelin-1 -- metabolism
- Endothelins -- metabolism
- Female
- Heart Failure -- drug therapy
- Humans
- Male
- Middle Aged
- Natriuretic Peptide, Brain -- drug effects
- Propanolamines -- pharmacology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.